Back to company

FUJIFILM Diosynth Biotechnologies Holdings Denmark ApS: Financial statements 2022

CVR: 31586569

FUJIFILM Diosynth Biotechnologies Holdings Denmark ApS (CVR 31586569) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 0 and a net result of DKK -325,276 compared with DKK -155,038 the year before. Equity amounted to DKK 3,255,101,976. The solvency ratio was 99.6%.

Revenue
0 kr.
Gross Profit
-204,104 kr.
Profit/Loss
-325,276 kr.
Equity
3,255,101,976 kr.
Total Assets
3,267,363,082 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20220-204 t.-325 t.3.3 mia.-
2021--183 t.-155 t.3.3 mia.-
2018--29 t.-23.4 mio.425.2 mio.-
2017--37 t.-30 t.448.6 mio.-
2016--104 t.-81 t.448.6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on FUJIFILM Diosynth Biotechnologies Holdings Denmark ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

About FUJIFILM Diosynth Biotechnologies Holdings Denmark ApS

FUJIFILM Diosynth Biotechnologies Holdings Denmark ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2008. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named BIOGEN (DENMARK) NEW MANUFACTURING ApS and BIOGEN IDEC (DENMARK) NEW MANUFACTURING ApS. The management consists of Lars Petersen. The company is owned by FUJIFILM Corporation. In 2025, the company reported a gross profit of DKK -242,387 and a net result of DKK -205,233 compared with DKK -191,005 the year before. Equity amounted to DKK 3,254,481,711.